591:
Svetlana A. Dambinova, Oleg K. Granstrem, Alexandre Tourov, Roberto
Salluzzo, Filippa Castello, and Galina A. Izykenova. Monitoring of Brain Spiking Activity and Autoantibodies to N-Terminus Domain of G1uR1 Subunit of AMPA Receptors in Blood Serum of Rats with Cobalt-Induced Epilepsy, Journal of
31:
402:
in the matter of development and use of brain markers for nervous system pathology Her research accomplishments were summarized in more than 350 scientific papers and 25 book chapters She co-edited 7 books including the textbook “Advanced
Functional Neurochemistry”, published in 2003 by St.
444:
674:
Weissman, J.D.; Khunteev, G.A.; Heath, R; Dambinova, S.A. (2011). "NR2 Antibodies: Risk
Assessment of Transient Ischemic Attack (TIA)/Stroke in Patients with History of Isolated and Multiple Cerebrovascular Events".
605:
Dambinova, SA; Izykenova, GA; Burov, SV; Grigorenko, EV; Gromov, SA (1997). "The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy".
403:
Petersburg State
University (Russia), “Biomarkers for TBI”, published in 2012 by RSC Publishing House (UK), and “Biomarkers for Cerebral Ischemia”, published in 2013 by Kosta, (Russia).
362:
and its significance in drug addiction. Within 1995-2000 Dambinova was invited as a
Visiting Professor in other non-profit, private and public research institutions in Italy, Germany,
383:
291:
165:
648:
Bokesch P.M., Izykenova G.A., Justice J.B., Easley K.A., Dambinova S.A.. NMDA receptor antibodies predict adverse neurological outcome after cardiac surgery in high-risk patients"
769:
Stanca, Delia Maria; Mărginean, Ioan
Constantin; Sorițău, Olga; Dragoș, Cristian; Mărginean, Mariana; Mureșanu, Dafin Fior; Vester, Johannes C.; Rafila, Alexandru (2015).
374:. Dambinova supervised the research of glutamate receptors significance in children's idiopathic epilepsy. Dambinova is ex-president of the Russian Society for
366:, United States, Sweden and Ireland. Between 1995 and 1999, Dambinova organized the Laboratory of Neurochemistry at the non-profit private medical center
250:. In 1976 Dambinova defended her PhD thesis "Histone RNA synthesizing activity in denervated skeletal muscles and neurotropic regulation" the specialty
986:
904:"Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke"
510:"Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke"
976:
818:
Gusev, E.I.; Skvortsova, V.I.; Dambinova, S.A.; et al. (2000). "Neuroprotective effects of glycine for therapy of acute ischemic stroke".
720:"Aortic stiffness is related to the ischemic brain injury biomarker N-methyl-D-aspartate receptor antibody levels in aortic valve replacement"
394:, Russia, and United States. Long-term professional collaboration with clinicians and educators guided her research on the gap between basic
420:
495:
Skoromets AA, Dambinova, SA, etc. The fundamental importance of new biomarkers. Medical academic journal. Volume number 9. 4. 2009
971:
195:
at
Laboratory of biomarkers at Medical Center "DeKalb", Atlanta, USA. Dambinova was awarded as Honored Worker of Science of the
358:. The research data obtained under Dambinova's leadership from 1992 to 2000 were devoted to the molecular organization of
299:
271:
981:
335:
243:
468:
Dambinova, SA; Granstrem, OK (2001). "The role of glutamate receptors in the mechanisms of formation of epilepsy".
664:
Dambinova S.A. Biomarkers for transient ischemic attack (TIA) and ischemic stroke. Clin Lab Int. 2008; 32(7):7-10.
150:
942:
Svetlana
Dambinova, Ronald L Hayes, Kevin K.W. Wang, Biomarkers for Traumatic Brain Injury, RSC Drug Discovery,
350:
and developed new approaches to early diagnosis of chronic pain and addiction by detecting autoantibodies to a
236:
84:
902:
Dambinova, S.A.; Khounteev, G.A.; Izykenova, G.A.; Zavolokov, I.G.; Ilyukhina, A.Y.; Skoromets, A.A. (2003).
593:
192:
966:
343:
315:
943:
771:"GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases"
382:. Since 2002, Dr. Dambinova research has focused on laboratory diagnostics of neurological disorders at
961:
228:
207:. The Head of the project of the International Department of Neurology SPBGMU them. Acad. Pavlov's.
295:
204:
549:
Dambinova, SA; Izykenova, GA (2002). "Recombinant mu-delta receptor as a marker of opiate abuse".
843:
700:
631:
574:
508:
Dambinova, SA; Khounteev, GA; Izykenova, GA; Zavolokov, IG; Ilyukhina, AY; Skoromets, AA (2003).
124:
925:
884:
835:
800:
751:
692:
623:
566:
531:
275:
915:
874:
827:
790:
782:
741:
731:
684:
615:
558:
521:
145:
653:
359:
355:
239:
at faculty "Chemistry of
Natural Compounds". In 1971 she attended two year traineeship at
879:
862:
795:
770:
746:
719:
562:
387:
375:
255:
119:
619:
30:
955:
421:"Svetlana A. Dambinova Ph.D., D.Sc: Executive Profile & Biography - Businessweek"
331:
327:
847:
704:
578:
496:
330:
cascade underlying brain pathology. Between 1980 and 2000, Dambinova contributed to
635:
395:
339:
287:
263:
251:
232:
114:
486:
Dambinova SA, 1988, Glutamate
Neuroreceptors, Leningrad, Nauka, P239 (in Russian)
259:
247:
160:
90:
286:
Between 1989 and 1990, Dambinova was invited by Dr. E. Freeze, Director of the
688:
318:. Her monograph “Neuroreceptors of Glutamate”, concerning the significance of
311:
399:
342:(about 60 publications out of a total of 280). Dambinova contributed to the
929:
888:
839:
804:
755:
696:
570:
535:
390:, experimental research and she is co-PI of multicenter clinical trials in
736:
627:
594:
http://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.1998.71052088.x/pdf
347:
303:
298:
gene project. Her research accomplishments included studying the role of
224:
220:
196:
188:
920:
903:
786:
526:
509:
351:
216:
184:
71:
58:
944:
http://pubs.rsc.org/en/content/ebook/978-1-84973-389-2#!divbookcontent
831:
183:(Russian: Светла́на Алекса́ндровна Дамбинова; born March 15, 1949, in
391:
371:
363:
307:
200:
718:
Kidher, E.; Patel, V.M.; Nihoyannopoulos, P.; et al. (2014).
323:
319:
227:, at 1966 she graduated from school with honors. She earned her
140:
240:
379:
368:
Oasi Maria Institute on Mental Retardation and Aging in Troina
334:
research of human deep intracranial electrical stimulation in
254:. In 1980 Dambinova organized the Laboratory of Functional
141:
Laboratory of biomarkers Dekalb Medical Center, Atlanta, GA
861:
Dambinova, S.A.; Khounteev, G.A.; Skoromets, A.A. (2002).
367:
346:
cerebral ischemia and pain treatment by small endogenous
267:
155:
863:"Multiple panel of biomarkers for TIA/stroke evaluation"
654:
http://stroke.ahajournals.org/content/37/6/1432.full.pdf
384:
First Pavlov State Medical University of St. Petersburg
241:
Siberian Institute of Plant Physiology and Biochemistry
166:
First Pavlov State Medical University of St. Petersburg
133:
107:
77:
66:
37:
21:
386:, Russia. She supervises the molecular studies of
497:http://old.petrsu.ru/Structure/MAJ/2009_4/16.html
191:neuroscientist, Doctor of Biological Sciences,
8:
270:, where she studied molecular properties of
246:. Dambinova continued postgraduate study at
378:(1994-2000) and a Member of the Council of
260:Research Institute of Experimental Medicine
248:Research Institute of Experimental Medicine
203:(1998). Known in the world for research of
161:Research Institute of Experimental Medicine
91:Research Institute of Experimental Medicine
775:Journal of Cellular and Molecular Medicine
262:, and in 1990 the Laboratory of Molecular
29:
18:
919:
878:
794:
745:
735:
525:
412:
7:
380:European Society for Neurochemistry
880:10.1161/01.str.0000014922.83673.86
563:10.1111/j.1749-6632.2002.tb04191.x
274:. In 1988, Dambinova obtained her
14:
268:Institute of Human Brain, Russia
156:Institute of Human Brain, Russia
987:Irkutsk State University alumni
219:, she was studied at school in
1:
977:Russian women neuroscientists
620:10.1016/s0022-510x(97)00150-0
300:ionotropic glutamate receptor
272:ionotropic glutamate receptor
336:neurodegenerative disorders
244:Russian Academy of Sciences
93:(PhD, 1976 and D.Sc., 1985)
1003:
689:10.1016/j.jns.2010.09.023
174:
151:Kennesaw State University
100:
28:
820:Cerebrovascular Diseases
237:Irkutsk State University
211:Education and early life
85:Irkutsk State University
972:Russian neuroscientists
193:Distinguished Professor
592:Neurochemistry, 1998,
316:traumatic brain injury
215:Dambinova was born in
16:Russian neuroscientist
445:"Alexander Skoromets"
551:Ann. N. Y. Acad. Sci
225:Republic of Buryatia
197:Republic of Buryatia
61:, Russian Federation
982:People from Irkutsk
737:10.1155/2014/970793
344:Parkinson's disease
296:glutamate receptors
205:glutamate receptors
921:10.1373/49.10.1752
787:10.1111/jcmm.12614
652:2006;37:1432-1436.
527:10.1373/49.10.1752
201:Russian Federation
181:Svetlana Dambinova
125:Glutamate receptor
42:Svetlana Dambinova
23:Svetlana Dambinova
832:10.1159/000016025
425:www.bloomberg.com
326:receptors in the
302:in mechanisms of
276:Doctor of Science
229:bachelor's degree
178:
177:
102:Scientific career
994:
946:
940:
934:
933:
923:
899:
893:
892:
882:
873:(5): 1181–1182.
858:
852:
851:
815:
809:
808:
798:
781:(9): 2253–2261.
766:
760:
759:
749:
739:
715:
709:
708:
671:
665:
662:
656:
646:
640:
639:
602:
596:
589:
583:
582:
546:
540:
539:
529:
505:
499:
493:
487:
484:
478:
477:
465:
459:
458:
456:
455:
441:
435:
434:
432:
431:
417:
360:opiate receptors
356:opiate receptors
146:Emory University
55:
51:
49:
33:
19:
1002:
1001:
997:
996:
995:
993:
992:
991:
952:
951:
950:
949:
941:
937:
914:(10): 1752–62.
901:
900:
896:
860:
859:
855:
817:
816:
812:
768:
767:
763:
717:
716:
712:
683:(1–2): 97–102.
673:
672:
668:
663:
659:
647:
643:
604:
603:
599:
590:
586:
548:
547:
543:
520:(10): 1752–62.
507:
506:
502:
494:
490:
485:
481:
467:
466:
462:
453:
451:
443:
442:
438:
429:
427:
419:
418:
414:
409:
294:to engage in a
284:
213:
170:
129:
96:
78:Alma mater
62:
56:
53:
47:
45:
44:
43:
24:
17:
12:
11:
5:
1000:
998:
990:
989:
984:
979:
974:
969:
964:
954:
953:
948:
947:
935:
894:
853:
810:
761:
724:Neurol Res Int
710:
666:
657:
641:
608:J. Neurol. Sci
597:
584:
541:
500:
488:
479:
470:Neurochemistry
460:
449:www.1spbgmu.ru
436:
411:
410:
408:
405:
388:neuroreceptors
376:Neurochemistry
283:
280:
256:Neurochemistry
212:
209:
176:
175:
172:
171:
169:
168:
163:
158:
153:
148:
143:
137:
135:
131:
130:
128:
127:
122:
120:Neurochemistry
117:
111:
109:
105:
104:
98:
97:
95:
94:
88:
81:
79:
75:
74:
68:
64:
63:
57:
52:March 15, 1949
41:
39:
35:
34:
26:
25:
22:
15:
13:
10:
9:
6:
4:
3:
2:
999:
988:
985:
983:
980:
978:
975:
973:
970:
968:
967:Living people
965:
963:
960:
959:
957:
945:
939:
936:
931:
927:
922:
917:
913:
909:
905:
898:
895:
890:
886:
881:
876:
872:
868:
864:
857:
854:
849:
845:
841:
837:
833:
829:
825:
821:
814:
811:
806:
802:
797:
792:
788:
784:
780:
776:
772:
765:
762:
757:
753:
748:
743:
738:
733:
729:
725:
721:
714:
711:
706:
702:
698:
694:
690:
686:
682:
678:
670:
667:
661:
658:
655:
651:
645:
642:
637:
633:
629:
625:
621:
617:
613:
609:
601:
598:
595:
588:
585:
580:
576:
572:
568:
564:
560:
556:
552:
545:
542:
537:
533:
528:
523:
519:
515:
511:
504:
501:
498:
492:
489:
483:
480:
475:
471:
464:
461:
450:
446:
440:
437:
426:
422:
416:
413:
406:
404:
401:
397:
393:
389:
385:
381:
377:
373:
369:
365:
361:
357:
353:
349:
345:
341:
337:
333:
332:neurochemical
329:
328:neurotoxicity
325:
321:
317:
313:
309:
305:
301:
297:
293:
289:
281:
279:
277:
273:
269:
265:
261:
257:
253:
249:
245:
242:
238:
234:
230:
226:
222:
218:
217:Irkuts Region
210:
208:
206:
202:
198:
194:
190:
186:
182:
173:
167:
164:
162:
159:
157:
154:
152:
149:
147:
144:
142:
139:
138:
136:
132:
126:
123:
121:
118:
116:
113:
112:
110:
106:
103:
99:
92:
89:
86:
83:
82:
80:
76:
73:
69:
65:
60:
54:(age 75)
40:
36:
32:
27:
20:
938:
911:
907:
897:
870:
866:
856:
826:(1): 49–60.
823:
819:
813:
778:
774:
764:
727:
723:
713:
680:
677:J Neurol Sci
676:
669:
660:
649:
644:
611:
607:
600:
587:
554:
550:
544:
517:
513:
503:
491:
482:
473:
469:
463:
452:. Retrieved
448:
439:
428:. Retrieved
424:
415:
396:neuroscience
354:fragment of
340:phantom pain
288:Neuroscience
285:
264:Neurobiology
252:biochemistry
233:biochemistry
214:
180:
179:
134:Institutions
115:Neuroscience
101:
962:1949 births
614:(1): 93–7.
557:: 497–514.
476:(1): 19–29.
290:Program at
199:(1996) and
67:Nationality
956:Categories
908:Clin. Chem
730:: 970793.
514:Clin. Chem
454:2016-04-28
430:2016-04-28
407:References
312:drug abuse
292:NINDS, NIH
87:(BA, 1971)
48:1949-03-15
400:neurology
930:14500616
889:11988587
848:16960474
840:10629347
805:26081945
756:25054065
705:24604289
697:20934192
579:84830624
571:12105125
536:14500616
348:peptides
304:epilepsy
282:Research
278:degree.
221:Ulan-Ude
796:4568929
747:4099039
636:6998084
628:9395130
352:peptide
189:Russian
187:) is a
185:Irkutsk
72:Mongols
70:Buryat-
59:Irkutsk
928:
887:
867:Stroke
846:
838:
803:
793:
754:
744:
703:
695:
650:Stroke
634:
626:
577:
569:
534:
392:Europe
372:Sicily
364:Poland
314:, and
308:stroke
235:from
223:city,
108:Fields
844:S2CID
701:S2CID
632:S2CID
575:S2CID
926:PMID
885:PMID
836:PMID
801:PMID
752:PMID
728:2014
693:PMID
624:PMID
567:PMID
532:PMID
398:and
338:and
324:AMPA
322:and
320:NMDA
38:Born
916:doi
875:doi
828:doi
791:PMC
783:doi
742:PMC
732:doi
685:doi
681:300
616:doi
612:152
559:doi
555:965
522:doi
266:at
258:at
231:in
958::
924:.
912:49
910:.
906:.
883:.
871:33
869:.
865:.
842:.
834:.
824:10
822:.
799:.
789:.
779:19
777:.
773:.
750:.
740:.
726:.
722:.
699:.
691:.
679:.
630:.
622:.
610:.
573:.
565:.
553:.
530:.
518:49
516:.
512:.
474:18
472:.
447:.
423:.
370:,
310:,
306:,
50:)
932:.
918::
891:.
877::
850:.
830::
807:.
785::
758:.
734::
707:.
687::
638:.
618::
581:.
561::
538:.
524::
457:.
433:.
46:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
